BioMarin Pharmaceutical Inc. to Join the NASDAQ-100 Index Beginning July 27, 2015

NEW YORK, July 22, 2015 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced that BioMarin Pharmaceutical Inc. (Nasdaq: BMRN), will become a component of the NASDAQ-100 Index® (Nasdaq: NDX), the NASDAQ-100 Equal Weighted Index (Nasdaq: NDXE) and the NASDAQ-100 Ex-Technology Index (Nasdaq: NDXX) prior to market open on Monday, July 27, 2015.  BioMarin Pharmaceutical Inc. will replace DIRECTV (Nasdaq: DTV).

BioMarin Pharmaceutical Inc. is headquartered in Novato, California, and has a market capitalization of approximately $22.7 billion. For more information about the company, go to www.bmrn.com.

About Nasdaq Global Indexes

Nasdaq Global Indexes has been creating innovative, market-leading, transparent indexes since 1971. Today, our index offering spans geographies and asset classes and includes diverse families such as the Dividend and Income (includes Dividend Achievers), Dorsey Wright, Fixed Income (includes BulletShares®), Global Equity, Green Economy, Nordic and Commodity indexes. We continuously offer new opportunities for financial product sponsors across a wide-spectrum of investable products and for asset managers to measure risk and performance. Nasdaq also provides exchange listing, custom index and design solutions to financial organizations worldwide.

About Nasdaq

Nasdaq (Nasdaq: NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,600 listed companies with a market value of approximately $9.6 trillion and more than 10,000 corporate clients. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com.

The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular financial product or an overall investment strategy. Neither The NASDAQ OMX Group, Inc. nor any of its affiliates makes any recommendation to buy or sell any financial product or any representation about the financial condition of any company or fund. Statements regarding Nasdaq’s proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

NDAQG

Media Contact:  Joseph Christinat, Nasdaq
+1.646.441.5121

Issuer & Investor Contact:  Carla Proto, Nasdaq
+1.203.926.3326

Source: The NASDAQ OMX Group, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $85 at Scotiabank
• Twin Valley Expands to Abilene with 8 Gigabit Fiber Network
• PHILADELPHIA EAGLES SELECT HELLAS' SYNTHETIC TURF SYSTEM THAT PRIORITIZES PERFORMANCE, SAFETY, & ENVIRONMENTAL SUSTAINABILITY